Keizo Koya
Vorstandsvorsitzender bei SOLA Biosciences LLC
Profil
Keizo Koya founded SOLA Biosciences LLC in 2016, where he is working as Chief Executive Officer from 2016.
Dr. Koya also formerly worked at Mirata BioPharma LLC, as Chief Executive Officer & Director, Fuji Immunopharmaceuticals Corp., as Director-Drug Discovery & Development from 1995 to 1997, Synta Pharmaceuticals Corp., as Senior Vice President-Drug Development from 2002 to 2012, Fuji Photo Film Co., Ltd., as Head-Pharmaceutical Research & Development from 1990 to 1995, and Shionogi Biomedical Laboratories KK, as Vice President-Research & Development in 2002.
Dr. Koya received his doctorate degree from Kyushu University.
Aktive Positionen von Keizo Koya
| Unternehmen | Position | Beginn |
|---|---|---|
SOLA Biosciences LLC
 SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Vorstandsvorsitzender | 01.06.2016 |
Ehemalige bekannte Positionen von Keizo Koya
| Unternehmen | Position | Ende |
|---|---|---|
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 06.04.2012 |
| Shionogi Biomedical Laboratories KK | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2002 |
| Fuji Immunopharmaceuticals Corp. | Corporate Officer/Principal | 01.08.1997 |
| Fuji Photo Film Co., Ltd. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.1995 |
Mirata Biopharma LLC
 Mirata Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Mirata Biopharma LLC operates as a pre-clinical stage immuno-oncology company. The firm focuses on developing the next generation of precision immuno-oncology therapeutics. The company was founded in 2017 and is headquartered in Natick, MA. | Vorstandsvorsitzender | - |
Ausbildung von Keizo Koya
| Kyushu University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
| Fuji Photo Film Co., Ltd. | Finance |
| Shionogi Biomedical Laboratories KK | Health Services |
| Fuji Immunopharmaceuticals Corp. | |
Mirata Biopharma LLC
Mirata Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Mirata Biopharma LLC operates as a pre-clinical stage immuno-oncology company. The firm focuses on developing the next generation of precision immuno-oncology therapeutics. The company was founded in 2017 and is headquartered in Natick, MA. | Commercial Services |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Health Technology |
